Skip to main content
VulnerabilityPublished Updated

CVE-2025-0893: Symantec Diagnostic Tool · Improper Privilege Management

Affects Symantec Diagnostic ToolSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 7.8 High.

Data as of 4 Nov 2026, 00:43 UTC

CVSS 3.1 base score
7.8High
How severe the flaw is on the 0–10 CVSS scale.

Thin evidence

One scorer or none
CVSS scores by source
CNA (symantec)CVSS 3.17.8
EPSS
0.1% chance of exploitation in 30 days – higher than 4% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CISA SSVC
Exploitation
No evidence of active exploitation and no public proof of concept
Automatable
Attackers cannot reliably automate steps 1–4 of the kill chain
Technical impact
Total control over the software or total information disclosure

CISA SSVC assessment, 2025-02-27.

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 19 Feb 2025

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 3 Nov 2026.

What to do

Affected software

ProductAffectedFixed in
SymantecSymantec Diagnostic ToolAffected
  • =3.0.78 or earlier
Fixed in–

AI-suggested

Until a fix is available, restrict access to the Symantec Diagnostic Tool and limit user privileges to reduce the risk of exploitation.

Description

Symantec Diagnostic Tool (SymDiag), prior to 3.0.79, may be susceptible to a Privilege Escalation vulnerability.

References

Community reviews

Loading reviews…